WILLMINGTON, Del., Sept. 9, 2019 /PRNewswire/ -- NeuroRX, a phase 3 biopharma company focused on development of NRX-101, an FDA-designated Breakthrough Therapy for Severe Bipolar Depression with Acute Suicidal Ideation, will present a corporate overview at today's H.C. Wainwright 21st Annual Global Investment Conference in New York. In addition to the presentation by Dr.

STOCKHOLM, Sept. 9, 2019 /PRNewswire/ -- A feasibility study performed as a Master Thesis at Uppsala University and supervised by Diamyd Medical, supports the use of ultrasound guided intralymphatic injections for clinical routine use. This pilot study is based on interviews with and answers to questionnaires from selected radiologists and

SANTA CLARA, Calif., Sept. 9, 2019 /PRNewswire/ -- With the future of the Affordable Care Act (ACA) soon to be decided by the case of Texas v. United States, eHealth, Inc. (NASDAQ: EHTH) (

SAN FRANCISCO, Sept. 9, 2019 /PRNewswire/ -- Healthline Media's popular health website Medical News Today (MNT) jumped to #3 in the online health information category

DURHAM, N.C., Sept. 9, 2019 /PRNewswire/ -- MindPath Care Centers, the state's largest outpatient mental and behavioral healthcare provider, is pleased to announce that Diego Garza, M.D., Vice President of Strategy and Innovation at MindPath Care Centers, has been invited to be a speaker at the North Carolina Medical Society (NCMS)'s second

SAN DIEGO, Sept. 9, 2019 /PRNewswire/ -- Epic Sciences, Inc. today announced the appointment of Joel Smith as its general counsel and executive vice president of corporate development. Mr. Smith joins the company's impressive roster of industry veterans."Joel's appointment comes at a pivotal time for Epic Sciences as we bui

WALNUT CREEK, Calif., Sept. 9, 2019 /PRNewswire/ -- Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, announced that Michael Choo, MD, Paradigm Chief Medical Officer and Senior Vice President, has been named a founding member of the National Limb Loss and Preservation Registry

TITUSVILLE, N.J., Sept. 9, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive results from two pivotal Phase 3 clinical studies (ASPIRE I & II) to evaluate the efficacy and safety of SPRAVATO™ (esketamine) CIII nasal spray in addition to comprehensive standard of care (SOC) in adult pati

NASHVILLE, Tenn., Sept. 9, 2019 /PRNewswire/ -- Ancient Nutrition has announced the launch of a first-of-its-kind product line designed to support one's holistic wellness rou

ATLANTA, Sept. 9, 2019 /PRNewswire/ -- Quality Executive Partners, Inc. (QxP), a globally recognized management consulting firm serving the life sciences industry, announced the commercial availability of Virtuosi®, an on-demand educational platform that leverages the power of virtual reality (VR).  Virtuosi is composed of digital technical courses, V